Home > Quotes > NVO > Company News

Novo Nordisk A/S News Headlines

NVO 
$159.36
*  
2.51
  negative  
1.55%
Get NVO Alerts
*Delayed - data as of Jun. 19, 2013 15:25 ET 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Sanofi Invests in Emerging Markets - Analyst Blog
4/1/2013 5:10:27 PM - Zacks.com

Novo Nordisk: Buy This 10 Year 27.47% CAGR Stock After Its Recent 16.94% Pullback
4/1/2013 9:12:00 AM - Seeking Alpha

Sanofi/Transgene Inks Immunotherapy Deal - Analyst Blog
3/28/2013 6:30:43 PM - Zacks.com

FDA Approves Novartis' TOBI Podhaler - Analyst Blog
3/28/2013 5:26:42 PM - Zacks.com

AstraZeneca Discusses Strategy - Analyst Blog
3/28/2013 5:26:18 PM - Zacks.com

Bristol-Myers Reaches 52-Week High - Analyst Blog
3/28/2013 10:29:19 AM - Zacks.com

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
3/28/2013 5:43:00 AM - Seeking Alpha

Sanofi Reports Lemtrada Data - Analyst Blog
3/27/2013 4:25:06 PM - Zacks.com

Good News for Roche - Analyst Blog
3/27/2013 9:28:12 AM - Zacks.com

FDA Panel Favors Abbott's MitraClip - Analyst Blog
3/25/2013 6:26:53 PM - Zacks.com

CHMP in Favor of Sanofi's Aubagio - Analyst Blog
3/25/2013 5:30:47 PM - Zacks.com

Lilly, Boehringer Ingelheim Start Diabetes Study - Analyst Blog
3/25/2013 5:29:14 PM - Zacks.com

Positive Data on Novo Nordisk Candidate - Analyst Blog
3/25/2013 4:27:50 PM - Zacks.com

Painless Play To Fatten Up Your Portfolio: Buy Arena
3/25/2013 1:28:00 PM - Seeking Alpha

Positive Data on Novartis' Gilenya - Analyst Blog
3/25/2013 12:27:32 PM - Zacks.com

Novartis' Jetrea Gets EU Approval - Analyst Blog
3/22/2013 12:24:05 PM - Zacks.com

AstraZeneca/Moderna Ink Deal - Analyst Blog
3/22/2013 12:22:33 PM - Zacks.com

Label Expansion for Roche's Pegasys - Analyst Blog
3/21/2013 6:24:43 PM - Zacks.com

Brazil Approves Pfizer-Protalix Gaucher Drug - Analyst Blog
3/21/2013 10:33:19 AM - Zacks.com

Sanofi/MACK Candidate Progresses - Analyst Blog
3/20/2013 4:29:05 PM - Zacks.com

Data on Novo Nordisk's VIctoza - Analyst Blog
3/20/2013 1:49:35 PM - Zacks.com

Data on Eli Lilly's Cialis - Analyst Blog
3/19/2013 6:47:37 PM - Zacks.com

AstraZeneca to Revamp R&D Structure - Analyst Blog
3/19/2013 5:47:17 PM - Zacks.com

Merck-Luminex' Alzheimer's Collaboration - Analyst Blog
3/19/2013 4:47:42 PM - Zacks.com

Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 21, 2013
3/19/2013 9:00:04 AM - NASDAQ.com News